Hasil Pencarian - Laura Amanda Vallejo-Aparicio
- Menampilkan 1 - 4 hasil dari 4
-
1
-
2
Potential healthcare resource use and associated costs of every 2 month injectable cabotegravir plus rilpivirine long-acting regimen implementation in the Spanish National Healthca... oleh Laura-Amanda Vallejo Aparicio, Victoria Neches García, Beatriz Hernández-Novoa, Gregorio Casado, Ferrán Jodar, Marco Pinel, Daniel Callejo Velasco
Diterbitkan 2024-08-01Dapatkan teks lengkap
Artikel -
3
Cabotegravir and Rilpivirine Long-Acting Antiretroviral Therapy Administered Every 2 Months is Cost-Effective for the Treatment of HIV-1 in Spain oleh Santiago Moreno, Antonio Rivero, Pere Ventayol, Vicenç Falcó, Miguel Torralba, Melanie Schroeder, Victoria Neches, Laura Amanda Vallejo-Aparicio, Isaac Mackenzie, Matthew Turner, Cale Harrison
Diterbitkan 2023-07-01Dapatkan teks lengkap
Artikel -
4
Cost–benefit analysis of the National Immunization Program in Spain oleh Alberto Pérez, María Fernández Prada, Natalia Cassinello, Laura Amanda Vallejo-Aparicio, Andrea García, Almudena González, Ana Durán, Néboa Zozaya, Irene Fernández, Mathilde Daheron, Álvaro Hidalgo, Ekkehard Beck, Antonio García Ruiz
Diterbitkan 2024-12-01Dapatkan teks lengkap
Artikel